We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

MINDRAY Patient Monitoring & Life Support

Provides medical devices and solutions in Patient Monitoring & Life Support read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Mindray Defibrillators Amongst the World’s First to Receive MDR Clearance

By HospiMedica International staff writers
Posted on 23 Jan 2023
Print article
Image: The BeneHeart series defibrillators have earned accreditation for their quality and effectiveness (Photo courtesy of Mindray)
Image: The BeneHeart series defibrillators have earned accreditation for their quality and effectiveness (Photo courtesy of Mindray)

In 2017, the European Union (EU) introduced its newest Medical Device Regulation (MDR) to replace the existing Medical Device Directive (MDD). The MDR establishes a more stringent regulatory framework to govern the production and distribution of medical devices, requiring companies to advance and demonstrate greater product development and quality control capacities, with a transition period currently extending to 2027 and 2028, depending on risk classification. Under the European Union's newest MDR, defibrillators, as a high-energy life-support device, have been up-classified to the highest Class III for direct impact on patients’ internal organs and systems, and thereby a potential risk of further injury or even life threat. This classification requires manufacturers to provide more details of technical documents and clinical evidence, and to go through a conformity assessment conducted by a notified body.

Mindray (Shenzhen, China) has received the CE marking for its defibrillation product family under the EU’s MDR. With the new rule tightening the controls for defibrillation devices, Mindray has become among the first manufacturers in the world to earn MDR accreditation for product quality and effectiveness. Four of Mindray’s BeneHeart series defibrillators have become among the first to earn certification under the EU’s tightened MDR controls. This includes three new models that will soon be launched, as well as the company’s already widely-used flagship BeneHeart D6.

Mindray’s BeneHeart series defibrillators, which have earned accreditation for quality and effectiveness, use mature 360J biphasic technology with automatic impedance compensation, which can significantly reduce the amount of current passing through the heart during defibrillation and lower the risk of potential damage to myocardial tissue and the patient’s skin. Automatic impedance compensation functionality can also measure impedance of the patient and automatically adjust discharge voltage and discharge time. Mindray’s newly-certified defibrillators reduce the entire defibrillation process to 7.5 seconds. Mindray has now received MDR certification for almost all its flagship products, including patient monitors, ventilators, electrocardiographs, and infusion pumps, reinforcing the company’s ability to continue to provide innovative and high-value solutions to healthcare professionals.

“These certifications are sound validation of our long-term efforts to secure robust product development and quality management system. Mindray’s product development is fully compliant with the ISO 13485 Medical Devices Quality Management System,” said Shao Lingyun, General Manager of Mindray Central R&D Management. “We have invested in the design and development and clinical validation of our products from the very beginning and worked closely with international healthcare professionals and institutions to continually improve our product effectiveness and secure a high and stable level of product quality. It is through these incremental efforts that Mindray is confident in bringing about meaningful changes to the healthcare practices and outcomes.”

Related Links:
Mindray

Gold Supplier
Temperature Monitor
ThermoScan Temperature Monitoring Unit
New
Electrical Suction Machine
TR-23CII
New
Medical Heating Blanket
SUN 5
New
Vital Signs Monitor
VSM – 300C

Print article
Radcal

Channels

AI

view channel
Image: The WHO has conditionally recommended the use of algorithms in assisting with pediatric tuberculosis diagnosis (Photo courtesy of Pexels)

New Evidence-Based Algorithms Could Improve Diagnosis of Pediatric Tuberculosis

Tuberculosis (TB) continues to be one of the most prevalent causes of death among younger populations worldwide. Research indicates that over 96% of the deadly TB cases in children under the age of 15... Read more

Surgical Techniques

view channel
Image: Robotic bronchoscopy is used to biopsy lung nodules to detect the presence of lung cancer (Photo courtesy of Pexels)

Robotic Bronchoscopy Enables Doctors to Biopsy Lung Nodules from Hard-to-Reach Areas

Bronchoscopy is a procedure commonly used to diagnose lung cancer and other lung diseases by biopsying lung nodules. Traditional bronchoscopy involves a doctor manually guiding a thin tube, known as a... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.